Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
resiquimod toll-like receptor 7 small molecule Successful target TTD , drugbank , DGIDB Genital Herpes[MeSHID:D006558]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Actinic keratosis[MeSHID:D055623]
Herpes Simplex Infections[MeSHID:D006561]		 10.61 investigational,phase 2 agonist
resiquimod toll-like receptor 7 small molecule Successful target TTD , drugbank , DGIDB Genital Herpes[MeSHID:D006558]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Actinic keratosis[MeSHID:D055623]
Herpes Simplex Infections[MeSHID:D006561]		 10.61 investigational,phase 2 unknown
resiquimod toll-like receptor 8 small molecule Clinical trial target TTD , drugbank , DGIDB Genital Herpes[MeSHID:D006558]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Actinic keratosis[MeSHID:D055623]
Herpes Simplex Infections[MeSHID:D006561]		 25.46 investigational,phase 2 unknown
resiquimod toll-like receptor 8 small molecule Clinical trial target TTD , drugbank , DGIDB Genital Herpes[MeSHID:D006558]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Actinic keratosis[MeSHID:D055623]
Herpes Simplex Infections[MeSHID:D006561]		 25.46 investigational,phase 2 agonist
click here to return to the previous page